Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzene SCHEMBL10702919 | 0.95 | TP53 (0.30) | TP53TSHR | |
| Selenic Acid SCHEMBL35103 | 0.82 | — | — | |
| Selenic Acid SCHEMBL5610795 | 0.76 | — | — | |
| Selenic Acid SCHEMBL1325102 | 0.76 | — | — | |
| Selenic Acid SCHEMBL1534342 | 0.76 | — | — | |
| Selenic Acid SCHEMBL6935901 | 0.76 | — | — | |
| Selenic Acid SCHEMBL1942468 | 0.76 | — | — | |
| Selenic Acid SCHEMBL383355 | 0.76 | — | — | |
| Selenic Acid SCHEMBL20557887 | 0.76 | — | — | |
| Selenic Acid SCHEMBL21332226 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115260260-A | Selenium-containing ribose compound with KGA inhibitory activity and application of synthetic method thereof | 杭州健昵福生物科技有限公司 | 2022-11-01 | — | — | CN | claimed |
| CN-107522698-B | Preparation method and intermediate of trabectedin | 浙江海正药业股份有限公司 | 2021-12-28 | — | — | CN | claimed |
| CN-110156965-B | Low band gap conjugated polymer containing cyclopentadienone naphthalimide and preparation method and application thereof | 湘潭大学 | 2021-06-01 | — | — | CN | claimed |
| US-10211410-B2 | Organic compound and electronic device using same | NICHEM FINE TECHNOLOGY CO., LTD (TW) | 2019-02-19 | — | — | US | claimed |
| US-20180040831-A1 | ORGANIC COMPOUND AND ELECTRONIC DEVICE USING SAME | NICHEM FINE TECHNOLOGY CO., LTD. (TW) | 2018-02-08 | — | — | US | claimed |
| JP-1224374-A | — | — | None | — | — | JP | disclosed |
| JP-4230294-A | — | — | None | — | — | JP | disclosed |
| JP-4230295-A | — | — | None | — | — | JP | disclosed |
| JP-6316591-A | — | — | None | — | — | JP | disclosed |
| CN-115348995-A | Ink composition | 多佛欧洲公司 | 2022-11-15 | — | — | CN | disclosed |
| CN-115260260-A | Selenium-containing ribose compound with KGA inhibitory activity and application of synthetic method thereof | 杭州健昵福生物科技有限公司 | 2022-11-01 | — | — | CN | disclosed |
| CN-113072576-B | Chiral sildenafil, synthetic method and application | 四川大学 | 2022-04-26 | — | — | CN | disclosed |
| CN-1087092-A | Novel 7 beta-substituted-4-aza-5 alpha-androstan-3-ones as 5 alpha-reductase inhibitors | MERCK & CO INC (US) | 1994-05-25 | — | — | CN | disclosed |
| CN-1085223-A | The 17-beta substitution-4-azepine-5 α-androstane-3-one derivative | ERBA CARLO SPA (IT) | 1994-04-13 | — | — | CN | disclosed |
| WO-1993014105-A1 | DIFLUOROMETHYLENANDROSTENONE DERIVATIVES AND PROCESS FOR THEIR PREPARATION | FARMITALIA CARLO ERBA S.R.L. (IT) | 1993-07-22 | — | — | WO | disclosed |
| EP-0548291-A1 | PYRIDYLTHIO OR PYRIDYLOXY ALKANOIC ACIDS | SMITHKLINE BEECHAM CORPORATION (US) | 1993-06-30 | — | — | EP | disclosed |
| JP-H04230294-A | SPECIFIC 17BETA-THIOBENZOYL-4-AZA-5ALPHA-ANDROST-1-ENE-3-ONES AS ANTI-ANDROGENIC AGENT | MERCK & CO INC | 1992-08-19 | — | — | JP | disclosed |
| JP-H04230295-A | NEW 17BETA-HYDROXYBENZOYL-4-AZA-5ALPHA-ANDROST-1-ENE-3-ONES BEING TESTOSTERONE REDUCTASE INHIBITOR | MERCK & CO INC | 1992-08-19 | — | — | JP | disclosed |
| WO-1992005156-A1 | PYRIDYLTHIO OR PYRIDYLOXY ALKANOIC ACIDS | SMITHKLINE BEECHAM CORPORATION (US) | 1992-04-02 | — | — | WO | disclosed |
| JP-H01224374-A | ERGOLINE DERIVATIVE | SANDOZ AG | 1989-09-07 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10211410-B2 | Organic compound and electronic device using same | SQOR, DDT, SQLE | TP53 3066/4885TSHR 4492/4885 |
| US-20180040831-A1 | ORGANIC COMPOUND AND ELECTRONIC DEVICE USING SAME | SQOR, DDT, SQLE | TP53 3066/4885TSHR 4492/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.